Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Betahistine Hydrochloride Oral Solution

Approval Number

国药准字H20133114

Company四川健能制药有限公司

Registration Date

September 20, 2022

Previous Approval Numbers

国药准字H20133114

Drug Information

Generic Name

盐酸倍他司汀口服液

Dosage Form

口服溶液剂

Strength

10ml:20mg

Drug Type

化学药品

Registration Date

September 20, 2022

Company Information

Applicant Company

Company Name四川健能制药有限公司

Company Address

四川省自贡市工业开发区

Manufacturing Company

Company Name四川健能制药有限公司

Company Address

四川省自贡市工业开发区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy